BioMelbourne Network Progressing BioIndustry

22nd May - BioMelbourne Network's Connecting Women in Biotechnology Luncheon
Register now.. More

Victorian BioPortal

Looking for Something?

The Victorian BioPortal is the largest online search engine for biotechnology in Victorian with over 2,000 individual listings.

Start your search now

BioMelbourne Network

The Building Global Bridges program provides grants of between $100,000 & $500,000 to Victorian life science companies to develop partnerships with Massachusetts companies in late stage life sciences R&D projects. The program helps Victorian innovation to accelerate, access expertise, develop skills & better reach global markets and international investors. Applications close 17 September 2013.

Building Global Bridges

Invion Limited $4.1 Million Entitlement Offer Fully Subscribed Further $1.3 Million Placement Completed

22 April 2015.  On 20 March 2015, Invion Limited (ASX: IVX) announced a 2 for 7, fully underwritten, non-renounceable Entitlement Offer for ordinary shares at an offer price of $0.025 (Entitlement Offer) to raise approximately $4.1 million, following on from its successful placement at the same price per share for a total capital raise of $5.0 million. Invion today is pleased to announce that t... read more…

Phosphagenics Initiates Oxycodone Patch Dosing in Phase 2 Clinical Trial

17 April 2015.  Australian drug delivery company Phosphagenics Limited (ASX:POH; OTCQX:PPGNY) has commenced dosing in its Phase 2 TPM®/Oxycodone patch trial (POH 035-13). Study POH 035-13 is a double-blind, randomised, cross-over Phase 2 clinical trial investigating the safety and efficacy of Phosphagenics’ TPM®/Oxycodone patch in up to 28 patients suffering post herpetic neuralgia (PHN).   Re... read more…

FDA Confirms Change of Ownership of 23 US Generic Drugs and IDT Successfully Manufactures First Batch of Tablets

13 April 2015.  IDT Australia Limited (IDT.AX) announces that the US Food and Drug Administration (FDA) has confirmed receipt of the change of ownership letters formally transferring ownership of the 23 generic drug products to IDT.   Formalising change of ownership is a process whereby the vendor and the purchaser both submit correspondence informing the FDA that the transfer of a drug regis... read more…

Phosphagenics Appoints Three New Directors

13 April 2015.  Australian drug delivery company, Phosphagenics Limited (ASX: POH; OTCQX: PPGNY), announces that it has appointed three new directors to The Board. The new directors include Dr Greg Collier, Mr Peter Lankau and the Company’s recently appointed CEO, Dr Ross Murdoch.Dr Greg Collier is currently the CEO of ASX listed company Invion Ltd, and has more than 20 years’ experience spanni... read more…

Trajan and University of Tasmania Secure Top Postdoctoral Fellows for ASTech

27 March 2015.  Trajan Scientific and Medical (Trajan) and University of Tasmania (UTAS) are delighted to secure three top scientists to oversee innovative research programs at ASTech, the ARC Training Centre for Portable Analytical Separation Technologies, supported by the Australian Research Council (ARC).ASTech is a collaboration between Trajan and UTAS combining industry knowledge and resea... read more…

LBT Granted First U.S. Patent for APAS® Technology

26 March 2015.  Australian medical technology company LBT Innovations Limited (ASX: LBT) has been awarded the first U.S. patent for its pioneering culture-plate analysis technology, the Automated Plate Assessment System (APAS®).Patent no. 8,896,706 relates to a novel method for ‘colour calibrating’ images captured by the APAS technology, which will make it easier for devices using APAS to accur... read more…

Employee Share Scheme reforms introduced into Parliament

26 March 2015.  The following information has been provided by EY regarding the introduction of Employee Share Scheme reforms into Parliament: Following the proposed reforms to the employee share scheme (ESS) rules announced on 14 October 2014, and a consultation process on the draft legislation last month, the Bill was introduced into Parliament this week. The key reforms contained in the B... read more…

Phosphagenics signs license agreement to expand TPM®-based animal nutrition products to the UK and Ireland.

25 March 2015.  Australian drug delivery company, Phosphagenics Limited (ASX: POH; OTCQX: PPGNY), announced that it has granted Integrated Animal Health (IAH) a four year exclusive license to manufacture and sell animal nutrition products that incorporate the Company’s proprietary vitamin E phosphate technology (TPM®). The products, which will be marketed under IAH’s Feed-Mate™ brand, target re... read more…

Dr Bronwyn Evans to Chair Industry Growth Centre for Medical Technologies and Pharmaceuticals

23 March 2015.  Dr Bronwyn Evans, Chief Executive Officer of Standards Australia, has been appointed as Chair of the Industry Growth Centre for Medical Technologies and Pharmaceuticals by Commonwealth Minister for Industry and Science Ian Macfarlane MP. The Australian government has allocated $188.5 million to establish five Industry Growth Centres in key growth sectors: advanced manufacturing;... read more…

Invion $5 Million Private Placement & Rights Issue

20 March 2015.  Australian drug development company Invion Limited (ASX: IVX) is pleased to announce that it has successfully raised $895,000 in a private placement to institutional and sophisticated investors and will now raise a further $4.1 million in a fully underwritten non-renounceable rights issue to existing shareholders.The institutional placement is for approximately 35.8 million full... read more…

MedTech's Got Talent Competition - Applications now Open!

6 March 2015.  Interested in medical technology entrepreneurship? Want $60,000 (plus additional prizes) to get your business or product concept off the ground? Applications for MedTech’s Got Talent are now open, with early bird deadline on 30 March (get feedback and revise your application to be more competitive!) and the final deadline on 8 April.  STC will be holding Medtech’s Got Talent info... read more…

Phosphagenics Decides to Sell BioElixia® Cosmetics Brand

25 February 2015.  Australian drug delivery company, Phosphagenics Limited (ASX: POH; OTCQX: PPGNY), has put its branded cosmetics division, BioElixia®, up for sale to allow resources to be refocused on the Company’s core areas of strength. Phosphagenics has recently received a number of expressions of interest in purchasing its range of Personal Care products sold under the BioElixia® brand.  ... read more…

Industry Growth Centre Appointments

19 February 2015.   The Minister for Industry and Science, the Hon Ian Macfarlane MP, announced three of the five Chairs of the Industry Growth Centres on the 17 February 2015.   The announced Chairs - Elizabeth Lewis-Gray (METS), Peter Schutz (Food and Agribusiness) and Andrew Stevens (Advanced Manufacturing) - are respected industry leaders with extensive industry expertise and board expe... read more…

Nominations open soon for the 2015 Prime Minister's Prizes for Science

17 February 2015.   Help us recognise Australia’s best scientists and teachers, by nominating them for one of the Prime Minister’s Prizes for Science.   We’re looking for: The heroes of Australian science whose significant contribution to the advancement of knowledge through science deserves recognition; Exceptional innovators from science and industry who have enhanced our economy, ... read more…

BioMelbourne Network Women in Leadership Awards 2015

13 February 2015.  The BioMelbourne Network is very pleased to announce the launch of our inaugural “Women in Leadership” awards, to celebrate, honour and profile outstanding women in the biotechnology, medtech and healthcare technology sector. These new awards are designed to celebrate women who exhibit leadership in their fields of expertise and have made outstanding contributions to advan... read more…

Research Australia Congratulates New NHMRC CEO on Appointment

12 February 2015.  CEO arrives at a time of growth and opportunity in health and medical research.Research Australia welcomes today’s announcement by the Minister for Health, the Hon Sussan Ley, that Professor Anne Kelso AO has been appointed as the new Chief Executive Officer of the National Health and Medical Research Council (NHMRC). Research Australia CEO Elizabeth Foley said the depth of ... read more…

Spinifex Pharmaceuticals Enhances CMC Team with Two Senior Appointments

11 February 2015.  Spinifex Pharmaceuticals, a company focused on the development of new drugs for the treatment of chronic pain, today announces that it has enhanced its Chemistry, Manufacturing & Controls (CMC) capability as it continues to build the management team to drive the development of its lead candidate, EMA401, in a number of chronic pain indications. Dr Peter Spargo has joined Spin... read more…

Otifex - First Phase I Clinical Study Successfully Completed

10 February 2015.  Otifex Therapeutics, an emerging Australian specialty pharmaceutical company developing a new treatment for the most common cause of acquired hearing loss in childhood, Otitis Media with Effusion (OME or ‘glue ear’), has successfully completed the first stage of its clinical development programme. The Phase 1a study, conducted at two clinical sites in Australia, was a random... read more…

Gordagen Expands Corporate and Clinical Expertise as Enters Next Phase of Development

6 February 2015.  Gordagen Pharmaceuticals Pty. Ltd., a private company commercialising natural tocotrienols as evidence-based dietary supplements and pharmaceuticals, is pleased to announce the bolstering of its capacity through the appointment of senior executives and clinical expertise.Under guidance of the Board, Chaired by Mr Fred Nadjarian, former Managing Director of Roche Products, and ... read more…

Sienna Appoints Dr Cliff Holloway as Interim CEO

5 February 2015.  Sienna Cancer Diagnostics Ltd, a Melbourne-based biotechnology company, focused on developing novel in vitro diagnostics tests for cancer, has today announced that Dr Cliff Holloway has been appointed interim Chief Executive Officer. Dr Holloway will replace Dr Kerry Hegarty and commence work on February 2.Dr Holloway brings extensive experience to the role, having held execut... read more…